THE CURRENT ROLE OF MACROLYDES IN THE TREATMENT OF BRONCHIAL ASTHMA

Authors

  • YAKUBOV Abdujalol Vahobovich
  • MUSAYEVA Lola Jurayevna
  • AKBAROVA Dilfuza Suratovna
  • SAIDOVA Shakhnoza Aripovna
  • ARIPDJANOVA Shaxlo Sardarovna
  • AVAZOVA Gulchekhra Nurillayevna

Keywords:

: bronchial asthma, treatment, exacerbation of the disease, macrolide antibiotics

Abstract

Despite the improvement of diagnosis and treatment, the prevalence and death rate of bronchial asthma in the world is increasing year by year. Modern domestic and foreign studies on the assessment of the level of effectiveness of antibacterial treatment in patients during exacerbation of bronchial asthma show conflicting results. The evidence for the effectiveness of macrolide therapy for asthma in adults is not well established and remains controversial. We analyzed literature data to investigate the efficacy and safety of macrolide treatment for asthma in adults and found that macrolide use may help reduce the frequency of exacerbations in eosinophilic, non-eosinophilic, and severe asthma exacerbations.

References

Avdeev S.N., Belevskiy A.S., Aisanov Z.R. Bronxial astma bilan og‘rigan bemorlarni tanishtirish uchun yangi yondashuvlar va algoritm. Amaliy pulmonologiya. 2019;1:3-5.

Hansen M., Scott A., McCullough A. va boshqalar. Har qanday ko‘rsatkich uchun platseboga qarshi makrolid antibiotiklarini qabul qilgan odamlarda noxush hodisalar. Cochrane ma’lumotlar bazasi tizimi Rev. 2019 yil 18-yanvar ;1 (1):CD011825. doi : 10.1002/14651858.CD011825.

Yudina L.V. Bronxial astmaning yuqumli kuchayishida azitromitsindan foydalanish . Ukraina salomatligi. 2015;2:3

Brusselle G., VanderStichele C., Jordens P., Deman R., Slabbynck H., Ringoet V. va boshqalar. Og‘ir astmada kuchayishning oldini olish uchun azitromitsin (AZISAST): ko‘p markazli randomizatsiyalangan ikki tomonlama ko‘r platsebo - nazorat ostida sinov. Toraks 2013 ;68 (4):322 - 9.

Reiter J, Demirel N, Mendy A va boshqalar. Astmani uzoq muddatli davolash uchun makrolidlar - randomizatsiyalangan klinik sinovlarning meta-tahlili. Allergiya 2013; DOI: 10.1111/all.12199.

Hahn DL, Grasmick M, Hetzel S, Yale S; AZMATICS ( AZithroMycin - Jamiyat sozlamalarida astma bo‘yicha sinov ) o‘quv guruhi. Kattalardagi bronxial astma uchun azitromitsin: samaradorlik sinovi. J Am Board Fam Med 2012 ;25:442 –59.

Jonston S., Szigeti M., Cross M. va boshqalar. Astmaning o‘tkir kuchayishi bilan og‘rigan kattalardagi bemorlar uchun standart yordamga qo‘shimcha sifatida og‘iz azitromitsinning samaradorligini baholash uchun randomizatsiyalangan, ikki tomonlama ko‘r, platsebo-nazoratli tadqiqot (AZALEA sinovi ) . Sautgempton (Buyuk Britaniya): NIHR Journals Library; 2016 ; 3 .

Cameron EJ, Chaudhuri R, Mair F, McSharry C, Greenlaw N, Weir CJ va boshqalar. Astma bilan kasallangan chekuvchilarda azitromitsinning tasodifiy nazorat ostida sinovi. evro Respira J ; 2013 (42): 1412-1415.

Gibson P., Yang I., Upham J. va boshqalar. Azitromitsinning doimiy nazoratsiz astma (AMAZES) bilan og‘rigan kattalardagi astma kuchayishi va hayot sifatiga ta’siri: randomizatsiyalangan , ikki marta ko‘r , platsebo-nazorat ostidagi sinov. Lancet.2017 ;390 ;659-668.

Hahn DL, Plane MB ,. Mahdi OS, Byrne GI. Uchuvchining ikkinchi darajali natijalari

astma PloS uchun azitromitsinni davolashning randomizatsiyalangan sinovi Klin sinovlari. 2006 ;1: 11 .

Sadeghdoust M., Mirsadraee M., Aligolighasemabadi F. ,. Xakzad MR, Hashemi A., Naghibi S. Azitromitsinning og‘ir doimiy astmada bronxial devor qalinligiga ta’siri: er-xotin ko‘r platsebo-nazoratli randomizatsiyalangan klinik sinov. Respir Med 2021 ;185:4 -9.

Sutherland ER, King TS, Icitovic N., BT Ameredes , E. Bleecker, HA Boushey va boshqalar. Suboptimal nazorat ostida astmani davolash uchun klaritromitsinning sinovi . J Allergiya klinikasi Immunol 2010 ;126:747 -753.

Fukuda Yosuke, Horita Nobuyuki, Aga Masaharu . Katta yoshdagi astma uchun makrolid davolashsining samaradorligi va xavfsizligi: tizimli tahlil va meta-tahlil. Nafas olish organlarini tekshirish . 2024; 62 ( 2 ): 206-215 .

Vestfal JF. Makrolid tomonidan induktsiyalangan P-450A (CYP) 3A4 sitoxromi bilan klinik ahamiyatga ega dori o‘zaro ta’siri: klaritromitsin, azitromitsin va diritromitsinga qaratilgan yangilanish . Britaniyalik Klinl J Farmakol . 2000 ; 50 (4): 285-95.

Moseley RH. Makrolid antibiotiklari. Antimikrobiyal va antifungal vositalarning gepatotoksisitesi. In: Giyohvand moddalardan kelib chiqqan jigar kasalligi. Kaplowitz N, DeLeve LD, muharrirlar. 3- nashr. Amsterdam, NL: Elsevier; 2013: 466-7.

Choi Y, Lim HS, Chung D, Choi J, Yoon D. Haqiqiy amaliyotda azitromitsin tomonidan qo‘zg‘atilgan QT uzayishi xavfini baholash. BioMed Research International. 2018. doi : 10.1155/2018/1574806.

Published

2024-12-23